// App-Quantinova.ai

: Mendelian randomization identifies a causal role for serum insulin-like growth factor-1 in hip osteoarthritis

Researchers

Presenter

  • A.E. Hartley

Principal Investigators

  • E. Sanderson

  • L. Paternoster

  • R. Granell

  • J.H. Tobias

  • C.L. Gregson

Medical Centers

  • University of Bristol, Bristol, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Musculoskeletal

Disease

  • Osteoarthritis

Biomarkers

  • Insulin-like growth factor 1

Drug/Treatment

  • Mecasermin

Outcome

  • N/A

Study Design

  • Observational

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved